Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT02410603
Official study title

Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

Study summary

The purpose of this study is to explore the detection of circulating tumor DNA, soluble immune markers, and the evaluation of peripheral blood mononuclear cells (PBMC).

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forLung Cancer · Lung Neoplasms

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 21, 2021 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Mayo Clinic

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Mayo Clinic
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Advanced (non-resectable) malignancy in the thorax
  • Age \>18 years old
  • Willing and able to provide consent
  • No prior history of neoadjuvant therapy
Reasons someone may not be able to joinExclusion criteria
  • Age \<18 years old
  • Unable to provide consent
  • Patients with hemoglobin less than 10 g/dL (to minimize the impact of potential iatrogenic anemia)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Mayo ClinicRochester, Minnesota

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 21, 2021. Always confirm current availability with the study team.

View original record ↗